Gilead Sciences Breaks Ground on New Manufacturing Center at California HQ

MT Newswires Live
Sep 04

Gilead Sciences (GILD) said Wednesday it started construction of a new Pharmaceutical Development and Manufacturing Technical Development Center at its headquarters in Foster City, California.

The project is part of the company's planned $32 billion investment in US innovation through 2030.

Gilead said the five-story, 180,000 square foot facility will feature digitally enabled systems, autonomous robotics, and real-time digital monitoring.

The project is expected to create more than 3,000 direct and indirect jobs, according to the company.

Gilead added that it is also currently developing a new research building and a biologics manufacturing facility at its headquarters.

Price: 112.77, Change: +0.06, Percent Change: +0.05

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10